The contemporary TV western "Longmire" may be finished filming for the foreseeable future, but several of its former cast ...

NEW YORK, Sept. 16 (UPI) --The contemporary TV western Longmire may be finished filming for the foreseeable future, but several of its former cast members have exciting new projects coming out ...

Drugmaker Eli Lilly is significantly lowering the prices of the two lowest doses of its blockbuster weight loss drug Zepbound, it said Tuesday, in a move to expand access and ease supply constraints.

Eli Lilly (LLY) announced it is cutting prices of its blockbuster weight-loss drug Zepbound after less than a year on the market. The company is pricing its 2.5mg doses at $399 per month and 5mg ...

On Tuesday, Pfizer (PFE) said it will enter the direct-to-consumer business, following the lead of a Big Pharma rival, Eli Lilly (LLY), which launched a similar plan in January. The new website ...

An FDA approval has officially lifted the curtain on a blockbuster market showdown between Novartis and Eli Lilly in early breast cancer. The FDA has greenlighted Novartis’ Kisqali, used in ...

Eli Lilly will now sell cheaper vials of Zepbound, presenting a direct challenge to telehealth companies that offer compounded versions of the medication. By Dani Blum With high demand for drugs ...

For context, the drug originally launched last year at a list price of $1,059, which Lilly said was approximately 20% lower than Novo Nordisk’s competing semaglutide products. Novo’s obesity ...

Eli Lilly is ramping up its campaign against imitations of its blockbuster appetite-suppressing drugs, seeking to put an end to a regulatory designation that has allowed cheaper, off-brand ...

Eli Lilly is announcing a new way to get its popular Zepbound drug. People who are in need of weight loss medications but do not have insurance coverage will soon have a new way to access one of ...